Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells.
暂无分享,去创建一个
Andreas Friedl | A. Friedl | C. Mundhenke | A. Rapraeger | Christoph Mundhenke | Brandon J Burbach | Alan C Rapraeger | B. Burbach
[1] M. Götte,et al. Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.
[2] D. Carey,et al. Syndecans: multifunctional cell-surface co-receptors. , 1997, The Biochemical journal.
[3] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[4] X. Bai,et al. Developmental changes in heparan sulfate expression: in situ detection with mAbs , 1992, The Journal of cell biology.
[5] B. Smoller,et al. Syndecan‐1 expression is diminished in acantholytic cutaneous squamous cell carcinoma , 1999, Journal of cutaneous pathology.
[6] R. Iozzo. Turnover of heparan sulfate proteoglycan in human colon carcinoma cells. A quantitative biochemical and autoradiographic study. , 1987, The Journal of biological chemistry.
[7] M. Jalkanen,et al. Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells , 1986, The Journal of cell biology.
[8] M. Jalkanen,et al. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Gelmann,et al. Regulation of vimentin gene transcription in human breast cancer cell lines. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[10] C. Yeaman,et al. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. , 1996, The Biochemical journal.
[11] I. Fuki,et al. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism , 1997, Current opinion in lipidology.
[12] G. Reekmans,et al. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. , 2001, Molecular biology of the cell.
[13] Robert Clarke,et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.
[14] M. Sheng,et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization , 2000, Nature Neuroscience.
[15] M. Jalkanen,et al. Molecular cloning of syndecan, an integral membrane proteoglycan , 1989, The Journal of cell biology.
[16] V. Hascall,et al. Cell surface heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.
[17] Alan C. Rapraeger,et al. Syndecan-Regulated Receptor Signaling , 2000, The Journal of cell biology.
[18] A. Woods. Syndecans: transmembrane modulators of adhesion and matrix assembly. , 2001, The Journal of clinical investigation.
[19] B. Klein,et al. A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1 , 1996, British journal of haematology.
[20] V. Hascall,et al. Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine. , 1984, The Journal of biological chemistry.
[21] K. Bame. Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. , 2001, Glycobiology.
[22] B. Smoller,et al. Acantholysis and spongiosis are associated with loss of syndecan‐1 expression , 2001, Journal of cutaneous pathology.
[23] G. Banting,et al. TGN38 and its orthologues: roles in post-TGN vesicle formation and maintenance of TGN morphology. , 1997, Biochimica et biophysica acta.
[24] H. Rochefort,et al. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. , 1994, Journal of cell science.
[25] Masato Kato,et al. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. , 1995, Molecular biology of the cell.
[26] A. Rapraeger,et al. Identification of an Adhesion Site within the Syndecan-4 Extracellular Protein Domain* , 1997, The Journal of Biological Chemistry.
[27] S. Nordling,et al. A prognostic value of syndecan-1 in gastric cancer. , 2000, Anticancer research.
[28] Bonnie F. Sloane,et al. Imaging proteolysis by living human breast cancer cells. , 2000, Neoplasia.
[29] M. von Zastrow,et al. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. , 2001, Trends in pharmacological sciences.
[30] J. Wijdenes,et al. Identification and location on syndecan‐1 core protein of the epitopes of B‐B2 and B‐B4 monoclonal antibodies , 1998, FEBS letters.
[31] S. Tumova,et al. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. , 2000, The international journal of biochemistry & cell biology.
[32] M. J. Stanley,et al. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. , 1999, American journal of clinical pathology.
[33] M. Hulett,et al. Heparanase: a key enzyme involved in cell invasion. , 2001, Biochimica et biophysica acta.
[34] J. Davies,et al. Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. , 1998, The International journal of developmental biology.
[35] L. Kopper,et al. Syndecan-1 expression in different soft tissue tumours. , 2001, Anticancer research.
[36] J. L. Wang,et al. Nonlysosomal processing of cell-surface heparan sulfate proteoglycans. Studies of I-cells and NH4Cl-treated normal cells. , 1987, The Journal of biological chemistry.
[37] I. Thesleff,et al. Epithelial-mesenchymal interactions in tooth morphogenesis: the roles of extracellular matrix, growth factors, and cell surface receptors. , 1991, Journal of craniofacial genetics and developmental biology.
[38] E. Gelmann,et al. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[39] H. Friess,et al. Syndecan‐1 expression is up‐regulated in pancreatic but not in other gastrointestinal cancers , 2000, International journal of cancer.
[40] G Murphy,et al. Proteolysis and cell migration: creating a path? , 1999, Current opinion in cell biology.
[41] Choll W. Kim,et al. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. , 1994, Molecular biology of the cell.
[42] R. Sanderson,et al. Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[43] Y. Kohgo,et al. Reduced expression of syndecan‐1 in human hepatocellular carcinoma with high metastatic potential , 1997 .
[44] T. Soukka,et al. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[45] M. Jalkanen,et al. The role of syndecan-1 in malignancies. , 1996, Annals of medicine.
[46] T. Roskams,et al. Heparan sulphate proteoglycan expression in human primary liver tumours , 1998, The Journal of pathology.
[47] R. Sanderson,et al. Heparan sulfate proteoglycans in invasion and metastasis. , 2001, Seminars in cell & developmental biology.
[48] H. Steven Wiley,et al. Regulation of Receptor Tyrosine Kinase Signaling by Endocytic Trafficking , 2001, Traffic.
[49] S. Grénman,et al. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. , 1999, Gynecologic oncology.
[50] M. Yanagishita. Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways. , 1992, The Journal of biological chemistry.
[51] O. Reizes,et al. Cell Surface Heparan Sulfate Proteoglycans: Selective Regulators of Ligand-Receptor Encounters* , 2000, The Journal of Biological Chemistry.
[52] P. Zimmermann,et al. The syndecans, tuners of transmembrane signaling , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] R. Gallo,et al. Developmental expression of the syndecans: possible function and regulation. , 1993, Development (Cambridge, England). Supplement.
[54] H. Hers,et al. Lysosomes and storage diseases , 1973 .
[55] P. Heikkilä,et al. Syndecan-1 expression has prognostic significance in head and neck carcinoma , 1999, British Journal of Cancer.